As respiratory outbreaks, mutations, emerging pathogens and growing resistance continue, having precise and timely diagnosis is pivotal to curbing transmission, contributing to clinical decision-making and supporting healthcare systems.
Our respiratory portfolio utilizes gold-standard PCR technology, enabling laboratories to automate, conduct multiplex testing and standardize workflows, bringing care closer to the patient.
Roche's diagnostic respiratory portfolio is built on the foundations of quality and efficiency. With almost 30 years of experience in respiratory research, we are dedicated to improving patient outcomes. We work closely with laboratorians to provide them with the necessary diagnostic systems and assays to enable patient care.
